Barclays PLC Increases Stake in OrthoPediatrics Corp. (NASDAQ:KIDS)

Barclays PLC grew its stake in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 319.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 25,298 shares of the company’s stock after purchasing an additional 19,264 shares during the quarter. Barclays PLC owned approximately 0.10% of OrthoPediatrics worth $686,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Quarry LP bought a new stake in shares of OrthoPediatrics in the third quarter worth about $25,000. International Assets Investment Management LLC grew its position in shares of OrthoPediatrics by 2,610.8% in the 3rd quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock worth $27,000 after buying an additional 966 shares during the last quarter. Quest Partners LLC purchased a new position in shares of OrthoPediatrics during the second quarter valued at approximately $34,000. BNP Paribas Financial Markets raised its holdings in shares of OrthoPediatrics by 125.1% during the third quarter. BNP Paribas Financial Markets now owns 3,471 shares of the company’s stock valued at $94,000 after acquiring an additional 1,929 shares in the last quarter. Finally, Quantbot Technologies LP raised its holdings in shares of OrthoPediatrics by 42.2% during the third quarter. Quantbot Technologies LP now owns 5,773 shares of the company’s stock valued at $157,000 after acquiring an additional 1,712 shares in the last quarter. Institutional investors own 69.05% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on KIDS shares. Needham & Company LLC reissued a “buy” rating and set a $42.00 price objective on shares of OrthoPediatrics in a research report on Friday, November 8th. Truist Financial reduced their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Finally, JMP Securities restated a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a report on Friday, September 13th.

OrthoPediatrics Stock Performance

Shares of OrthoPediatrics stock opened at $23.18 on Thursday. OrthoPediatrics Corp. has a 12 month low of $21.02 and a 12 month high of $35.99. The firm has a market capitalization of $561.33 million, a P/E ratio of -18.85 and a beta of 1.14. The company has a current ratio of 7.17, a quick ratio of 3.68 and a debt-to-equity ratio of 0.19. The business has a fifty day simple moving average of $24.63 and a two-hundred day simple moving average of $27.70.

OrthoPediatrics Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.